Premium Reports
 Download Report Brief  Download Full Report    Zoom in charts

Preferences

   Bookmark

Related Series

Ambulatory EMR Purchasing 2016
|
2016
Ambulatory EMR Perception 2014
|
2014
Ambulatory EMR Perception 2012
|
2012
Ambulatory EMR 2011
|
2011
Ambulatory EMR Buying
|
2010
Purchasing an Ambulatory EMR Solution
|
2009
Ambulatory EMR Perception 2008
|
2008
Ambulatory EMR Perception 2006
|
2006

 End chart zoom
ePrescribing/Ambulatory EMR Perception Study 2005 ePrescribing/Ambulatory EMR Perception Study 2005
* A page refresh may be necessary to see the updated image

ePrescribing/Ambulatory EMR Perception Study 2005

March 15, 2005

Current Time Inside Cache Tag Helper: 10/19/2021 3:02:58 PM and Model.reportId = 229

KLAS' ePrescribing/Ambulatory EMR Perception Study 2005 focuses on the perception of HIT users and decision makers relative to ePrescribing/Ambulatory EMR systems.

HtmlReportContent Current Time Inside Cache Tag Helper: 10/19/2021 3:02:58 PM and Model.reportId= 229 and Model.HtmlReportContent_LastWriteTimeUtcInTicks=637406508603472826

The report includes information on which ePrescribing/Ambulatory EMR vendors are most likely to be included in today’s selection process, key reasons healthcare facilities do or do not have an ePrescribing/Ambulatory EMR system and vendor ratings in areas such as: Vision, Ability to Deliver Product, Physician Acceptance, End User Presentation, Cost/Value, Technology/Architecture and Integration.

Vendors in the study include: A4, Epic, GE, IDX, McKesson, Misys, NextGen, and WebMD.

 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.